Clinical trial
Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in…
NCT00284908 · STEBA France, Industry · Completed
Key facts
| NCT number | NCT00284908 |
|---|---|
| Title | Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers |
| Official title | Pharmacodynamic Dose-Response of S-Tenatoprazole-Na (STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers |
| Lead sponsor | STEBA France, Industry |
| Collaborators | STEBA LABORATORIES LTD. |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Esophagitis, Gastroesophageal Reflux, Stomach Ulcer, Duodenal Ulcer |
| Intervention type | Drug |
| Interventions | S-Tenatoprazole-Na (STU-Na) |
| Enrollment | 32 |
| Start date | Sep 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Feb 1, 2006 |
| Last update posted | Mar 24, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: